Form 8-K · Current report
Fastenal 8-K, filed Oct 14, 2026
- Filed
- CIK
- 0000815556
- Accession no.
- 0000815556-26-000046
Summary
Fastenal reported third-quarter 2026 results with net sales of $2.46 billion, up 15.5% year-over-year on a daily-sales basis, operating margin of 21.5% (up 90 basis points), and diluted earnings per share of $0.35 versus $0.29 a year earlier. The company also lowered its 2026 goal for weighted FASTBin and FASTVend device signings to between 27,000 and 29,000 MEUs from a prior range of 28,000 to 30,000.
Key points
- Third-quarter net sales were $2,463.3 million, up 15.5% from $2,133.3 million a year earlier, with the same number of business days in both periods.
- Operating income rose 20.2% to $530.8 million, and net income rose 19.7% to $401.6 million.
- Operating cash flow was $422 million, or 105% of net income, and the company returned $328 million to shareholders through dividends and buybacks, 82% of net income.
- Fastenal signed 7,484 weighted FASTBin and FASTVend devices in the quarter and cut its full-year 2026 signing goal to 27,000-29,000 MEUs.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. On October 14, 2026, the Registrant issued a press release announcing the results of its most recently ended fiscal quarter, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Item 9.01. Financial Statements and Exhibits. INDEX TO EXHIBITS Exhibit Number Description of Document 99.1 Press release dated October 14, 2026. 104 The cover page from the Current Report on Form 8-K formatted in Inline XBRL. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.